Joint Formulary & PAD

Betahistine hydrochloride - Tinnitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Betahistine hydrochloride
Indication :
Tinnitus
Group Name :
Keywords :
Ringing in ears
Brand Names Include :
Serc
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Betahistine hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Tinnitus.

  • No records returned.

Committee Recommendations (1)

The Surrey & North West Sussex Area Prescribing Committee (APC) do not recommend the use of betahistine for Tinnitus. This is in line with recommendations made by NICE (NG155) Tinnitus: assessment and management (NG155) NICE states:

'Do not offer' betahistine for tinnitus